The Advisory Board Company (NASDAQ:ABCO) announced financial results for the quarter ended June 30, 2015. Revenue increased 30% to $184.7 million in the quarter ended June 30, 2015 up from to $141.8 million for the quarter ended June 30, 2014. Adjusted revenue, which adjusts for the effect on revenue of fair value adjustments to acquired deferred revenue, increased 35% to $191.3 million for the quarter ended June 30, 2015, up from $141.8 million for the quarter ended June 30, 2014. Contract value increased 35% to $741.7 million as of June 30, 2015, up from $548.4 million as of June 30, 2014. The Advisory Board Company (NASDAQ:ABCO) belongs to Services sector. Its net profit margin is -3.60% and weekly performance is -19.76%. On last trading day company shares ended up $46.99. The Advisory Board Company (NASDAQ:ABCO) distance from 50-day simple moving average (SMA50) is -14.35%.
Ensco PLC earnings conference call or presentation Thursday, July 30, 2015 at 3:00:00pm GMT. Ensco plc (NYSE:ESV) shares increased 0.56% in last trading session and ended the day at $16.15. ESV Gross Margin is 55.60% and its return on assets is -19.50%. Ensco plc (NYSE:ESV) quarterly performance is -40.21%.
Groupon, Inc. (NASDAQ:GRPN) is scheduled to announce its second-quarter financial results before the market opens on Friday. In a report issued Monday, Bank of America Merrill Lynch analysts Paul Bieber and Justin Post previewed the results, which they expect to be in-line with their estimates and slightly ahead of the Street. On 05 August, Groupon, Inc. (NASDAQ:GRPN) shares increased 0.63% and was closed at $4.76. GRPN EPS growth in last 5 year was -61.50%. Groupon, Inc. (NASDAQ:GRPN) year to date (YTD) performance is -42.37%.
Fibrocell Science (NASDAQ:FCSC) is scheduled to be issuing its Q215 quarterly earnings data on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.Fibrocell Science, Inc. (NASDAQ:FCSC) ended the last trading day at $7.48. Company weekly volatility is calculated as 8.26% and price to cash ratio as 9.77. Fibrocell Science, Inc. (NASDAQ:FCSC) showed a weekly performance of 17.43%.